Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the

October 27, 2023

J&J, Legend’s Carvykti clears a type of blood cancer in ‘nine out of 10’ patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 11, 2024

Harris seeks to tie expanded Medicare drug price negotiation to home care policy

WASHINGTON — Vice President Harris is proposing to use cuts to the pharmaceutical industry’s profits in Medicare to fund a home care benefit for people

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.